IL148816A0 - Benzodiazepine derivatives - Google Patents

Benzodiazepine derivatives

Info

Publication number: IL148816A0
Authority: IL; Israel
Prior art keywords: benzodiazepine derivatives; benzodiazepine; derivatives
Prior art date: 1999-10-15

Application number

IL14881600A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-15

Filing date

2000-09-29

Publication date

2002-09-12

2000-09-29 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2002-09-12 Publication of IL148816A0 publication Critical patent/IL148816A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

IL14881600A 1999-10-15 2000-09-29 Benzodiazepine derivatives IL148816A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99120520		1999-10-15
PCT/EP2000/009553 WO2001029011A2 (en)	1999-10-15	2000-09-29	Benzodiazepine derivatives as metabotropic glutamate receptor antagonists

Publications (1)

Publication Number	Publication Date
IL148816A0 true IL148816A0 (en)	2002-09-12

Family

ID=8239207

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14881600A IL148816A0 (en)	1999-10-15	2000-09-29	Benzodiazepine derivatives
IL148816A IL148816A (en)	1999-10-15	2002-03-21	Derivatives of benzodiazepine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL148816A IL148816A (en)	1999-10-15	2002-03-21	Derivatives of benzodiazepine

Country Status (34)

Country	Link
US (1)	US6407094B1 (xx)
EP (1)	EP1224174B1 (xx)
JP (1)	JP3857138B2 (xx)
KR (1)	KR100480320B1 (xx)
CN (1)	CN1195522C (xx)
AR (1)	AR026029A1 (xx)
AT (1)	ATE250039T1 (xx)
AU (1)	AU774451B2 (xx)
BR (1)	BR0014859A (xx)
CA (1)	CA2386974C (xx)
CO (1)	CO5261604A1 (xx)
CZ (1)	CZ20021653A3 (xx)
DE (1)	DE60005386T2 (xx)
DK (1)	DK1224174T3 (xx)
EG (1)	EG24079A (xx)
ES (1)	ES2204704T3 (xx)
GC (1)	GC0000263A (xx)
HR (1)	HRP20020259A2 (xx)
HU (1)	HUP0203142A3 (xx)
IL (2)	IL148816A0 (xx)
JO (1)	JO2262B1 (xx)
MA (1)	MA26831A1 (xx)
MY (1)	MY125540A (xx)
NO (1)	NO327817B1 (xx)
NZ (1)	NZ517999A (xx)
PE (1)	PE20010681A1 (xx)
PL (1)	PL357418A1 (xx)
PT (1)	PT1224174E (xx)
RU (1)	RU2259360C2 (xx)
SI (1)	SI1224174T1 (xx)
TR (1)	TR200201023T2 (xx)
WO (1)	WO2001029011A2 (xx)
YU (1)	YU26202A (xx)
ZA (1)	ZA200202544B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE261945T1 (de)	1999-10-15	2004-04-15	Hoffmann La Roche	Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
HUP0400851A3 (en)	2001-04-12	2010-03-29	Hoffmann La Roche	Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists ii, process for their preparation and pharmaceutical compositions containing them
WO2002083665A1 (en) *	2001-04-12	2002-10-24	F. Hoffmann-La Roche Ag	DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
US20070122353A1 (en)	2001-05-24	2007-05-31	Hale Ron L	Drug condensation aerosols and kits
US7458374B2 (en)	2002-05-13	2008-12-02	Alexza Pharmaceuticals, Inc.	Method and apparatus for vaporizing a compound
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
US7585493B2 (en)	2001-05-24	2009-09-08	Alexza Pharmaceuticals, Inc.	Thin-film drug delivery article and method of use
US7090830B2 (en)	2001-05-24	2006-08-15	Alexza Pharmaceuticals, Inc.	Drug condensation aerosols and kits
US6949542B2 (en)	2002-02-06	2005-09-27	Hoffman-La Roche Inc.	Dihydro-benzo[b][1,4]diazepin-2-one derivatives
CN1694701A (zh) *	2002-09-10	2005-11-09	诺瓦提斯公司	治疗包括成瘾与抑郁症在内的与mGLU受体相关疾病的mGLU受体拮抗剂
WO2004104490A1 (en)	2003-05-21	2004-12-02	Alexza Pharmaceuticals, Inc.	Self-contained heating unit and drug-supply unit employing same
ATE374030T1 (de) *	2003-07-25	2007-10-15	Hoffmann La Roche	Kombination eines mglur2 antagonists und eines ache inhibitors zur behandlung von akuten und/oder chronischen neurologischen krankheiten
FR2862969A1 (fr) *	2003-11-28	2005-06-03	Oreal	Procede de preparation de derives paraphenylenediamine a groupement pyrrolidinyle, substitue par un radical azote, et composes intermediaires
DE102004010893A1 (de) *	2004-03-06	2005-09-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7540286B2 (en)	2004-06-03	2009-06-02	Alexza Pharmaceuticals, Inc.	Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en)	2004-08-12	2011-04-14	Alexza Pharmaceuticals, Inc.	Aerosol drug delivery device incorporating percussively activated heat packages
CN101056857B (zh)	2004-11-05	2010-12-01	弗·哈夫曼-拉罗切有限公司	异烟酸衍生物的制备方法
AP2007004047A0 (en)	2005-01-20	2007-06-30	Pfizer Ltd	Substituted triazole derivatives as oxtocin antagonists
TWI417095B (zh)	2006-03-15	2013-12-01	Janssen Pharmaceuticals Inc	１，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
TW200845978A (en)	2007-03-07	2008-12-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en)	2007-03-07	2009-01-01	Janssen Pharmaceutica Nv	3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US20080216828A1 (en)	2007-03-09	2008-09-11	Alexza Pharmaceuticals, Inc.	Heating unit for use in a drug delivery device
AU2008240802B2 (en)	2007-04-19	2012-07-05	F. Hoffmann-La Roche Ag	Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives
NZ584148A (en) *	2007-09-14	2011-05-27	Ortho Mcneil Janssen Pharm	1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
CA2697399C (en)	2007-09-14	2016-01-19	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
MY152078A (en)	2007-09-14	2014-08-15	Ortho Mcneil Janssen Pharm	1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones
US8399420B2 (en) *	2007-09-26	2013-03-19	Mount Sanai School of Medicine	Azacytidine analogues and uses thereof
RU2492170C9 (ru) *	2007-11-14	2013-12-27	Орто-Макнейл-Янссен Фармасьютикалз, Инк.	Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
AU2009289784B2 (en)	2008-09-02	2012-03-22	Addex Pharma S.A.	3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
ES2466341T3 (es)	2008-10-16	2014-06-10	Janssen Pharmaceuticals, Inc.	Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
WO2010060589A1 (en)	2008-11-28	2010-06-03	Ortho-Mcneil-Janssen Pharmaceuticals, Inc.	Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
AU2010246609B2 (en)	2009-05-12	2013-09-05	Addex Pharma S.A.	1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
NZ596053A (en)	2009-05-12	2013-05-31	Janssen Pharmaceuticals Inc	1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en)	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN101891706B (zh) *	2010-04-09	2013-05-29	复旦大学	3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
US8642626B2 (en)	2010-07-29	2014-02-04	Taisho Pharmaceutical Co., Ltd.	Ethinyl-pyrazole derivative
EP2661435B1 (en)	2010-11-08	2015-08-19	Janssen Pharmaceuticals, Inc.	1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103298810B (zh)	2010-11-08	2016-03-16	杨森制药公司	1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2643320B1 (en)	2010-11-08	2015-03-04	Janssen Pharmaceuticals, Inc.	1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JP2012153674A (ja) *	2011-01-28	2012-08-16	Astellas Pharma Inc	ジ（アリールアミノ）アリール化合物の製造方法及びその合成中間体
EP2925292A1 (en)	2012-10-23	2015-10-07	F. Hoffmann-La Roche AG	Mglu2/3 antagonists for the treatment of autistic disorders
JO3368B1 (ar)	2013-06-04	2019-03-13	Janssen Pharmaceutica Nv	مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar)	2013-09-06	2019-03-13	Janssen Pharmaceutica Nv	مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
DK3096790T3 (da)	2014-01-21	2019-10-07	Janssen Pharmaceutica Nv	Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse
KR20220038826A (ko)	2014-01-21	2022-03-29	얀센 파마슈티카 엔.브이.	대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
US9895324B2 (en)	2014-03-26	2018-02-20	University Of Kentucky Research Foundation	Halogenated diarylacetylenes and methods of treating cancer
RU2016144702A (ru)	2014-04-23	2018-05-24	Ф. Хоффманн-Ля Рош Аг	Антагонисты mglu2/3 для лечения интеллектуальной недостаточности
US9969726B2 (en)	2014-06-10	2018-05-15	Sanford-Burnham Medical Research Institute	Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
CN106243050B (zh) *	2016-08-10	2019-09-06	安徽恒星制药有限公司	一种适合工业化生产氯巴占的方法
CN109836356B (zh) *	2017-11-24	2022-03-08	沈阳化工研究院有限公司	一种芳甲醚衍生物及其应用
US12214118B2 (en)	2018-02-02	2025-02-04	Alexza Pharmaceuticals, Inc.	Electrical condensation aerosol device
RU2702358C1 (ru) *	2019-06-04	2019-10-08	Федеральное государственное бюджетное научное учреждение Уфимский федеральный исследовательский центр Российской академии наук	Способ получения 2,2,4-триалкил-2,3-дигидро-1Н-1,5-бензодиазепинов
CN114349779B (zh) *	2021-12-29	2023-09-26	智仑超纯环氧树脂(西安)有限公司	一种改性二氧化硅颗粒除氯剂及其制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU437924A1 (ru) *	1972-07-28	1974-07-30	Институт Горного Дела Ан Казахской Сср	Цифровой автоматический измеритель скорости распространени упругих волн
SU749836A1 (ru) *	1978-02-13	1980-07-23	Днепропетровский Ордена Трудового Красного Знамени Государственный Университет Им. 300-Летия Воссоединения Украины С Россией	Способ получени 4-метил2,3-дигидро1н-1,5-бензодиазепинонов-2
AU6514296A (en) *	1995-07-31	1997-02-26	Novo Nordisk A/S	Heterocyclic compounds, their preparation and use
NZ505207A (en) *	1997-11-21	2003-10-31	Nps Pharma Inc	Metabotropic glutamate receptor antagonists for treating central nervous system diseases

2000
- 2000-09-29 WO PCT/EP2000/009553 patent/WO2001029011A2/en not_active Ceased
- 2000-09-29 IL IL14881600A patent/IL148816A0/xx active IP Right Grant
- 2000-09-29 HR HR20020259A patent/HRP20020259A2/xx not_active Application Discontinuation
- 2000-09-29 CA CA002386974A patent/CA2386974C/en not_active Expired - Fee Related
- 2000-09-29 JP JP2001531811A patent/JP3857138B2/ja not_active Expired - Fee Related
- 2000-09-29 DE DE60005386T patent/DE60005386T2/de not_active Expired - Lifetime
- 2000-09-29 EP EP00969347A patent/EP1224174B1/en not_active Expired - Lifetime
- 2000-09-29 CN CNB008142742A patent/CN1195522C/zh not_active Expired - Fee Related
- 2000-09-29 RU RU2002110104/04A patent/RU2259360C2/ru not_active IP Right Cessation
- 2000-09-29 PT PT00969347T patent/PT1224174E/pt unknown
- 2000-09-29 YU YU26202A patent/YU26202A/sh unknown
- 2000-09-29 HU HU0203142A patent/HUP0203142A3/hu unknown
- 2000-09-29 BR BR0014859-8A patent/BR0014859A/pt not_active Application Discontinuation
- 2000-09-29 NZ NZ517999A patent/NZ517999A/en unknown
- 2000-09-29 AT AT00969347T patent/ATE250039T1/de not_active IP Right Cessation
- 2000-09-29 DK DK00969347T patent/DK1224174T3/da active
- 2000-09-29 PL PL00357418A patent/PL357418A1/xx unknown
- 2000-09-29 TR TR2002/01023T patent/TR200201023T2/xx unknown
- 2000-09-29 AU AU79102/00A patent/AU774451B2/en not_active Ceased
- 2000-09-29 KR KR10-2002-7004838A patent/KR100480320B1/ko not_active Expired - Fee Related
- 2000-09-29 SI SI200030210T patent/SI1224174T1/xx unknown
- 2000-09-29 ES ES00969347T patent/ES2204704T3/es not_active Expired - Lifetime
- 2000-09-29 CZ CZ20021653A patent/CZ20021653A3/cs unknown
- 2000-10-10 PE PE2000001083A patent/PE20010681A1/es not_active Application Discontinuation
- 2000-10-10 JO JO2000169A patent/JO2262B1/en active
- 2000-10-11 GC GCP2000950 patent/GC0000263A/en active
- 2000-10-12 CO CO00077957A patent/CO5261604A1/es not_active Application Discontinuation
- 2000-10-13 AR ARP000105386A patent/AR026029A1/es unknown
- 2000-10-13 US US09/687,240 patent/US6407094B1/en not_active Expired - Fee Related
- 2000-10-13 MY MYPI20004817A patent/MY125540A/en unknown
- 2000-10-14 EG EG20001310A patent/EG24079A/xx active
2002
- 2002-03-21 IL IL148816A patent/IL148816A/en not_active IP Right Cessation
- 2002-03-28 ZA ZA200202544A patent/ZA200202544B/xx unknown
- 2002-04-10 NO NO20021690A patent/NO327817B1/no not_active IP Right Cessation
- 2002-04-15 MA MA26601A patent/MA26831A1/fr unknown

Also Published As

Publication number	Publication date
JP2003512359A (ja)	2003-04-02
DK1224174T3 (da)	2004-01-26
HUP0203142A2 (hu)	2003-02-28
ES2204704T3 (es)	2004-05-01
DE60005386D1 (de)	2003-10-23
SI1224174T1 (en)	2003-12-31
AR026029A1 (es)	2002-12-26
CN1379765A (zh)	2002-11-13
AU774451B2 (en)	2004-06-24
ZA200202544B (en)	2003-09-23
JP3857138B2 (ja)	2006-12-13
NO20021690L (no)	2002-04-10
US6407094B1 (en)	2002-06-18
CO5261604A1 (es)	2003-03-31
NO327817B1 (no)	2009-09-28
NO20021690D0 (no)	2002-04-10
EP1224174B1 (en)	2003-09-17
CA2386974C (en)	2009-10-13
GC0000263A (en)	2006-11-01
ATE250039T1 (de)	2003-10-15
EP1224174A2 (en)	2002-07-24
HUP0203142A3 (en)	2003-03-28
HRP20020259A2 (en)	2004-04-30
IL148816A (en)	2006-10-31
KR20020038954A (ko)	2002-05-24
AU7910200A (en)	2001-04-30
WO2001029011A3 (en)	2001-11-08
PT1224174E (pt)	2004-01-30
YU26202A (sh)	2004-12-31
BR0014859A (pt)	2002-07-16
DE60005386T2 (de)	2004-06-24
RU2259360C2 (ru)	2005-08-27
EG24079A (en)	2008-05-11
CZ20021653A3 (cs)	2002-08-14
WO2001029011A2 (en)	2001-04-26
TR200201023T2 (tr)	2002-09-23
MA26831A1 (fr)	2004-12-20
MY125540A (en)	2006-08-30
KR100480320B1 (ko)	2005-04-07
PL357418A1 (en)	2004-07-26
HK1051038A1 (en)	2003-07-18
CA2386974A1 (en)	2001-04-26
CN1195522C (zh)	2005-04-06
PE20010681A1 (es)	2001-06-28
NZ517999A (en)	2004-07-30
JO2262B1 (en)	2004-10-07

Publication	Publication Date	Title
GC0000207A (en)	2006-03-29	Benzodiazepine derivatives
EG24079A (en)	2008-05-11	Benzodiazepine derivatives
EG23817A (en)	2007-09-19	4-Phenyl-pyridine derivatives
IL148167A0 (en)	2002-09-12	Amino-triazolopyridine derivatives
GC0000183A (en)	2006-03-29	3-Phenyl-pyridine derivatives
GC0000338A (en)	2007-03-31	5-Phenyl-pyrimidine derivatives
IL145739A0 (en)	2002-07-25	13-methyl-erythromycin derivatives
IL148058A0 (en)	2002-09-12	Substituted 2-dialkylaminoalkylbiphenyl derivatives
IL148837A0 (en)	2002-09-12	Isoxazolecarboxamide derivatives
GC0000191A (en)	2006-03-29	4-Phenyl-pyrimidine derivatives
IL155035A0 (en)	2003-10-31	Benzodiazepine derivatives
GC0000256A (en)	2006-11-01	Ethanesulfonyl-piperidine derivatives
GB0026485D0 (en)	2000-12-13	›-Carboline derivatives
IL147636A0 (en)	2002-08-14	3-amino-2-benzyl-1-phenyl-propane derivatives
IL150132A0 (en)	2002-12-01	Cyclopenteneone derivatives
IL145949A0 (en)	2002-07-25	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
PL351407A1 (en)	2003-04-22	Thio-oxindole derivatives
IL146282A0 (en)	2002-07-25	Thio-oxindole derivatives
GB9907134D0 (en)	1999-05-19	Antimor napthylcombretastatin derivatives
SI1226131T1 (en)	2004-04-30	Isoxazolecarboxamide derivatives
SI1178984T1 (en)	2003-08-31	1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
SI1200445T1 (en)	2004-02-29	Thienopyranecarboxamide derivatives

Legal Events

Date	Code	Title	Description
2007-06-17	FF	Patent granted
2007-06-17	KB	Patent renewed